[Federal Register Volume 64, Number 74 (Monday, April 19, 1999)]
[Notices]
[Page 19187]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-9752]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institutes of Child Health and Human 
Development Special Emphasis Panel, Extremity Constraint Induced 
Therapy Eval (Excite) Trial.
    Date: May 5, 1999.
    Time: 1:00 pm to 2:30 pm.
    Agenda: To review and evaluate grant applications.
    Place: 6100 Executive Blvd., Room 5E01, Rockville, MD 20852 
(Telephone Conference Call).
    Contact Person: Hameed Khan, Scientific Review Administrator, 
Division of Scientific Review, National Institute of Child Health 
and Human Development, National Institutes of Health, 6100 Executive 
Blvd., Room 5E01, Bethesda, MD 20892, (301) 496-1485.

(Catalog of Federal Domestic Assistance Program Nos. 93.209, 
Contraception and Infertility Loan Repayment Program; 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research, National 
Institutes of Health, HHS)

    Dated: April 13, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-9752 Filed 4-16-99; 8:45 am]
BILLING CODE 4140-01-M